New drug launch sends Lupin shares soaring to record highs! Find out what’s next

Pallavi Madhiraju- September 5, 2024 0

Lupin Limited, a global pharmaceutical major, has seen its share price reach a 52-week high following the launch of its generic Mirabegron Extended-Release Tablets, 50 ... Read More

Zydus Lifesciences wins FDA approval for Amantadine Capsules, secures 180-day exclusivity

Pallavi Madhiraju- August 27, 2024 0

Zydus Lifesciences Limited, along with its subsidiaries and affiliates, has achieved a significant regulatory milestone by receiving final approval from the United States Food and ... Read More

Tentative approval granted to Alembic Pharmaceuticals for pulmonary hypertension treatment by FDA

Pallavi Madhiraju- July 13, 2024 0

Alembic Pharmaceuticals Limited has achieved a significant milestone by securing tentative approval from the US Food & Drug Administration (USFDA) for its Selexipag for Injection, ... Read More

Zydus Lifesciences receives tentative FDA approval for Azilsartan Medoxomil Tablets

Pallavi Madhiraju- July 4, 2024 0

Zydus Lifesciences Limited has achieved a significant milestone with the tentative approval from the United States Food and Drug Administration (USFDA) to market Azilsartan Medoxomil ... Read More

Alembic Pharmaceuticals gains FDA approval for Icatibant Injection

Pallavi Madhiraju- June 18, 2024 0

Alembic Pharmaceuticals Limited has achieved a significant milestone with the US Food & Drug Administration’s (USFDA) final approval of its Abbreviated New Drug Application (ANDA) ... Read More

Gland Pharma gains FDA approval for Edaravone Injection, set to treat ALS

Pallavi Madhiraju- May 7, 2024 0

Gland Pharma Limited, a prominent player in the generic injectable-focused pharmaceutical industry, has received approval from the United States Food and Drug Administration (USFDA) for ... Read More

Zydus Lifesciences launches Mirabegron Extended-Release Tablets in US market

Pallavi Madhiraju- April 23, 2024 0

Zydus Lifesciences Limited has announced the launch of Mirabegron Extended-Release Tablets, 25 mg, in the US market, following the final approval from the United States ... Read More

Strides Pharma Science gets FDA approval for Fluoxetine Tablets for depressive disorders

Pallavi Madhiraju- April 9, 2024 0

Strides Pharma Science Limited (Strides) has made a notable advancement in the field of mental health treatment by securing approval from the United States Food ... Read More

Gland Pharma receives USFDA approval for first generic Eribulin Mesylate Injection

Pallavi Madhiraju- April 7, 2024 0

In a significant advancement for generic pharmaceuticals, Gland Pharma Limited, a company specializing in generic injectable-focused pharmaceutical products, has announced receiving approval from the United ... Read More

Zydus Lifesciences receives tentative FDA approval for Letermovir tablets

Pallavi Madhiraju- March 24, 2024 0

In a significant development for patients undergoing bone marrow or kidney transplants, Zydus Lifesciences Limited has been granted tentative approval by the United States Food ... Read More